Namur, Belgium – CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was organized by the University of Namur, also the coordinator of the European Project, entitled “Ecosystem for RApid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines” (ERAMET).

CVBF’s contribution to the ERAMET project was showcased during the “Challenges and Opportunities with Connecting Questions, Data, and Methods” section. Claudia Pansieri shared CVBF’s expertise in enabling the adoption of Modelling & Simulation (M&S) techniques, gained through the EU-funded project DEEP (DEferiprone Evaluation in Paediatrics) an FP7 GA n.261483, which aimed to study the efficacy and safety of deferiprone in children affected by β-thalassemia and other transfusion-dependent haemoglobinopathies.

CVBF will lend its expertise across multiple work packages (WP1-WP7), including European Project Management, Regulatory Science, Data Management & Standardization and Biostatistics. The active participation in this European Project solidifies our position at the vanguard of international collaborations on addressing regulatory needs in the development of orphan and paediatric medicines.

For more information about the project, follow the link: https://www.erametproject.eu/